Email this article Benign ovarian tumors and their role in reproductive function disorders
- Authors: Kulakov V.I.1, Gataulina R.G.1, Sarkisov S.E.1, Beloglazova S.E.1, Egova L.S.1, Karamyshev V.К.1, Yurmatova N.V.1
-
Affiliations:
- Scientific Centre of Obstetrics, Gynecology and Perinatology, RAMS
- Issue: Vol 54, No 5S (2005)
- Pages: 54-55
- Section: Reviews
- URL: https://journals.eco-vector.com/jowd/article/view/87411
- DOI: https://doi.org/10.17816/JOWD87411
- ID: 87411
Cite item
Abstract
Objective: to reveal especiallities of reproductive function disorders in patients with benign ovarian tumors.
Full Text
Objective: to reveal especiallities of reproductive function disorders in patients with benign ovarian tumors.
Materials and methods. 2044 women with benign ovarian tumors and tumor-like mass and reproductive function disorders were observed. Endoscopic methods (laparoscopy and hysteroscopy) were carried out in all patients as usually with following pathomorphologic investigation of intraoperative samples.
Results, the primary infertility was marked in 53,2%, the secondary one - at 46,8% of observations. Ovarian tumors were revealed at 40,5% of patients, tumor-like mass - at 59,5%.
Most of ovarian tumors were epithelial. Among tumorlike mass endomethriomas prevailed. One third of patients had combination of benign ovarian tumors, 59,1% of patients had both benign ovarian tumors and different endometrial and myometrial pathology, including multiple fibroid. External genital endometriosis and pelvic adhesions more often accompanied tumor-like mass. The most patients of benign ovarian tumors characterized by metabolic disorders (decreased blood concentration of retinol, carotinoids, albumin, elictrolitis), hypothyroidism and dishormonal diseases of mammae. The examination of immune system changes in patients with benign ovarian tumors confirmed the presence of systemic disorders.
Conclusion. These data can be a confirmation of the opinion that benign ovarian tumors are not local process but systemic disease developed as a consequence of metabolic, hormonal and immune disorders.
About the authors
V. I. Kulakov
Scientific Centre of Obstetrics, Gynecology and Perinatology, RAMS
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Moscow
R. G. Gataulina
Scientific Centre of Obstetrics, Gynecology and Perinatology, RAMS
Email: info@eco-vector.com
Russian Federation, Moscow
S. E. Sarkisov
Scientific Centre of Obstetrics, Gynecology and Perinatology, RAMS
Email: info@eco-vector.com
Russian Federation, Moscow
S. E. Beloglazova
Scientific Centre of Obstetrics, Gynecology and Perinatology, RAMS
Email: info@eco-vector.com
Russian Federation, Moscow
L. S. Egova
Scientific Centre of Obstetrics, Gynecology and Perinatology, RAMS
Email: info@eco-vector.com
Russian Federation, Moscow
V. К. Karamyshev
Scientific Centre of Obstetrics, Gynecology and Perinatology, RAMS
Email: info@eco-vector.com
Russian Federation, Moscow
N. V. Yurmatova
Scientific Centre of Obstetrics, Gynecology and Perinatology, RAMS
Email: info@eco-vector.com
Russian Federation, Moscow
References
Supplementary files
